2 recruiting, 1 active not recruiting, 1 not yet recruiting. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow Type 1 Interferonopathies: new trials by email Literature Review of Type 1 Interferonopathies trials Research Report on Type 1 Interferonopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies biological samples - Systememic Lupus Erythematosus, Systemic Sclerosis (SSc) | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 120 | 2026-12-01 | 2026-09-24 |
| Combining Gene Editing and iPS to Study and Treat Monogenic Autoinflammatory Diseases Autoinflammatory Disease, Type 1 Interferonopathies | Recruiting | Istituto Giannina Gaslini | 6 | 2026-03-25 | 2026-10-22 | |
| Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies IMSB301 - Type 1 Interferonopathies | Phase 1 | Recruiting | ImmuneSensor Therapeutics Inc. | 6 | 2026-01-12 | 2026-01-23 |
| A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies BI 3000202_low dose, BI 3000202_high dose - Type 1 Interferonopathies | Phase 1 | Active not recruiting | Boehringer Ingelheim | 16 | 2025-07-29 | 2026-10-14 |
Connective Tissue Diseases (1) · Myositis (1) · Scleroderma, Systemic (1)
Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Boehringer Ingelheim (1) · Hospices Civils de Lyon (1) · ImmuneSensor Therapeutics Inc. (1) · Istituto Giannina Gaslini (1)
France (2) · Italy (2) · Australia (1) · Belgium (1) · Germany (1) · Israel (1) · Portugal (1) · Spain (1) · United Kingdom (1) · United States (1)